Oncology Research
Innovative clinical trials focusing on breast cancer treatments, particularly exploring new therapies for HER2-positive and hormone receptor-positive variants. Studies include novel combinations of targeted therapies and immunotherapy approaches.
- Advanced breast cancer therapies
- HER2-positive treatment strategies
- Non-small cell lung cancer interventions
Research includes evaluation of drugs like trastuzumab deruxtecan and combination therapies targeting specific cancer mutations.
Neurological Disorders
Comprehensive studies investigating treatments for multiple sclerosis and neurodegenerative conditions. Research focuses on both relapsing and progressive forms of MS, along with early-stage Alzheimer’s disease.
- Multiple sclerosis therapies
- Alzheimer’s disease treatments
- Cognitive function studies
Trials evaluate medications like ocrelizumab and semaglutide for various neurological conditions.
Inflammatory Conditions
Advanced research into inflammatory bowel diseases, including studies on Crohn’s Disease and Ulcerative Colitis. Trials evaluate novel therapeutic approaches and combination treatments.
- Crohn’s Disease management
- Ulcerative Colitis treatments
- Combination therapy approaches
Studies investigate medications such as risankizumab and ozanimod for long-term disease management.
